INTRODUCTION
Recently, we reported high seroprevalence (age-dependent up to >20%) of autoantibodies (AB) directed against N-methyl-D-aspartate-receptor subunit NR1 (NMDAR1) in both healthy and neuropsychiatrically ill subjects (N=4236) 1 .
Neuropsychiatric syndrome relevance was restricted to individuals with compromised blood-brain-barrier (BBB), e.g. APOE4 carrier status or post-neurotrauma, both clinically and experimentally 2, 3 . We now wondered whether NMDAR1-AB would be similarly seroprevalent in multiple sclerosis (MS) patients with their high likelihood of (recurring) BBB disturbance, as indirectly evidenced here as well as in clinical routine by an increased albumin quotient, i.e. a disturbed blood-CSF-barrier (BCB) 4 . In the following, the term BBB/BCB will therefore be used throughout. Importantly, we asked whether NMDAR1-AB would be present also in the CSF, at least of seropositive individuals with BBB/BCB leakage.
METHODS

Participants and AB measurements
MS (N=270) and neuropsychiatric disease control (DC) subjects (N=207) were recruited in Magdeburg and Munich for biomarker studies (Table1). Subject data were collected in accordance with ethical guidelines and the Helsinki Declaration.
Sample selection was unbiased, i.e. sera and CSF collection (including determination of albumin quotients; Table1) concluded before analysis of AB was planned.
NMDAR1-AB determination:
Commercially available standard procedures for clinical diagnosis, recombinant immunofluorescence tests (Euroimmun, Lübeck, Germany), were used to detect NMDAR-AB in serum and CSF, based on HEK293 cells transfected with NMDAR NR1 subunits 5, 6 . Seropositivity for NMDAR1-AB of IgG, IgM, or IgA isotypes (using respective second AB against human Ig; Euroimmun) was assessed by 2 researchers independently (for sample stainings see
Figure1) 5, 6 .
Tetanus-AB determination: Serum and CSF titers of tetanus-AB were measured using a tetanus IgG ELISA kit (Sekisui Diagnostics, LLC, USA) over a BioTek EL808 
Statistical analysis
Group differences in categorical and continuous variables were assessed using Chisquare and Mann-Whitney U test, respectively. Two-way ANOVA was employed to assess tetanus AB concentrations by BCB leakage and diagnosis. Statistical analyses were performed using SPSS for Windows version 17.0 (IBM-Deutschland GmbH, Munich, Germany). , we additionally performed serological analyses for these AB. We replicated our earlier result on a new cohort of N=1086 individuals, including the subjects of the present study (Table2), strengthening our finding that influenza seropositivity is related to the formation of NMDAR1-AB.
RESULTS
We
In individuals with serum-CSF pairs available (total N=271: N=119 MS; N=152 DC), altogether N=26 were seropositive for NMDAR1-AB. Surprisingly, only 1 out of the We thus hypothesized that the brain may act as 'immunoprecipitator' of serum AB directed against brain antigens, binding nearly all available AB molecules that pass through the BBB, thereby preventing drainage of a detectable amount of NMDAR1-AB into the CSF. In contrast, AB not expected to specifically bind to brain tissue, should appear in measurable amounts in the CSF, with quantities depending on BBB/BCB function.
In a first approach to prove this hypothesis, we determined in serum and CSF of our cohort the titers of vaccination-induced, abundantly present tetanus-AB (IgG), which
should not bind to brain antigens. In healthy individuals, the expected transfer over 6 an intact BBB/BCB into the CSF for IgG is 1/500 of the serum concentration 4 . Indeed, ).
Five days after application, plasma titers of both AB were lower in ApoE -/-mice with their open BBB than in WT littermates (p=0.004). CSF was negative for NMDAR1-AB in all mice, but distinctly positive for GFP-AB in 5/6 ApoE -/-mice and 1/5 WT mice. All brain regions analyzed in both genotypes were negative for GFP-AB. In contrast, NMDAR1-AB were recovered in prefrontal cortex, hippocampus, cerebellum, brain stem and spinal cord at high titers mainly in ApoE -/-mice, and to a lesser degree and in lower titers in WT mice (Figure2B-C). The recovered titers showed a regionally different pattern. This is interesting with respect to the known widespread distribution of NMDAR1 all over the central nervous system 10-12 and should motivate further study. Hitherto unexplained is the overall negative result for the olfactory bulb, even though NMDAR1 is also highly expressed there in adult mice 12 .
DISCUSSION
The present translational study supports the concept of the brain acting as ′immunoprecipitator′: Brain-antigen directed AB are strongly bound to brain tissue and thereby prevented from drainage into the CSF whereas non-brain bound AB appear in the CSF in amounts expected from the literature 4 . The BBB/BCB intactness versus leakiness plays a critical role regarding the titers measured in brain and CSF. Importantly, the present data should make clinicians aware that serum NMDAR1-AB may modulate brain functions also in absence of measurable titers in CSF. In cases where pathological significance of circulating NMDAR1-AB is suspected, the BBB/BCB intactness should be tested. This may soon be possible even by routine MRI 13 . In contrast, the high NMDAR1-AB levels reported in CSF of patients with NMDAR encephalitis 5, 15 , are likely derived from additional intrathecal synthesis, cause high (′oversaturated′) brain levels, severe acute symptoms, and distinct spillover into the CSF.
Regarding factors that predispose to NMDAR1-AB formation, we confirmed here our previously reported association with influenza A and B seropositivity 2 . Considerations of potential molecular mimicry accounting for this association are still speculative. But even though the underlying molecular mechanism is presently unclear, it may help to explain the high seroprevalence of NMDAR1-AB with increasing age.
A limitation of the present study is the fact, that mouse experiments were performed with IgG AB only. Therefore, kinetics of IgA and IgM in brain/CSF remain subject to further work. Nevertheless, in our earlier studies, using IgG, IgA and IgM NMDAR1-AB derived from human serum in the ApoE -/-mouse model 2 , a comparable consequence of all AB classes could be demonstrated. The same holds true for our findings in ischemic stroke patients where the Ig class did not seem to matter regarding the effects of serum NMDAR1-AB on evolution of lesion size 8 .
8
To conclude, our translational study may shed new light on the understanding of potential symptomatic consequences of serum AB directed against brain antigens.
Whereas leakiness of the BBB has a major role and should be evaluated in cases where pathological relevance of circulating NMDAR1-AB is suspected, negative results regarding AB titers in CSF may not be suitable to exclude brain effects. 
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